North America Aneurysmal Subarachnoid Hemorrhage Drugs Market Size, and Growth Outlook (2026–2034)
North America dominates the market due to well-established healthcare infrastructure, strong reimbursement policies, and a high incidence of brain aneurysms. The presence of leading pharmaceutical companies and continuous research initiatives also contribute to the region’s leading position. Increasing adoption of …